Inhaled Insulin

Human trials of Alveair insulin pulmonary technology about to begin

Published in Obesity and Diabetes Week, January 19th, 2004

Coremed, Inc., has announced that it will soon begin a series of human trials using its Alveair insulin pulmonary technology that is inhaled, not injected.

Since its discovery around 80 years ago, insulin dosage is traditionally standardized in "units" measurement. Coremed's Alveair pulmonary prototype features a hand-held device that delivers inhaled insulin in units, making it possible for the direct substitution of injectable insulin.

Exclusively dedicated to the development of oral insulin, Coremed, Inc., has conducted some of the most intensive preclinical biological trials of oral insulin anywhere, resulting in its published data presented at...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week

Source: Obesity and Diabetes Week (2004-01-19)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry